Company intelligence
Accelerating Clinical Trials Ltd
ACT specialises in delivering UK blood cancer studies in collaboration with two established networks TAP and IMPACT
Research Services
Birmingham, GB
26 employees
Founded 2021
5 public signals
About Accelerating Clinical Trials Ltd
A not-for-profit company, any surplus income is reinvested for blood cancer patients’ benefit. Delivery of both academic investigator initiated and industry sponsored clinical trials in haemato-oncology are accelerated with the resource and expertise of ACT and the networks, TAP and IMPACT.
Verified activity
Signals from Accelerating Clinical Trials Ltd
5 published signals
Capital & Finance
Accelerating Clinical Trials Ltd announced a new funding round for the IMPACT Stem Cell Transplant Clinical Trials Partnership and the haemato-oncology Trials Acceleration Programme, with funding available to NHS Trusts or Health Boards of up to £50,000 per year.
Reported by Accelerating Clinical Trials Ltd
Presence & Recognition
Accelerating Clinical Trials Ltd participated in World Leukaemia Day 2026 alongside Cure Leukaemia and the DIDACT Foundation.
Reported by Accelerating Clinical Trials Ltd
People
Accelerating Clinical Trials Ltd is hiring a Clinical Research Associate (CRA) or Senior Clinical Research Associate (SCRA) for a fully remote UK role requiring 3 years of experience in Pharma, Biotech or CRO settings, ICH GCP knowledge, UK clinical research regulations, study start-up, monitoring, and site management.
Reported by Accelerating Clinical Trials Ltd
Capital & Finance
Accelerating Clinical Trials Ltd will soon open ATICUS, a paediatric network, with support from Cure Leukaemia.
Reported by Accelerating Clinical Trials Ltd
People
Accelerating Clinical Trials Ltd is hiring a Clinical Research Assistant to join the Clinical Operations team.
Reported by Amy De Sa